5th Edition of Addiction World Conference 2026

Abstract

Background: Mallorca is becoming increasingly important for international patients seeking confidential and intensive treatment for substance-use disorders. Within our clinic’s international addiction-treatment population, patients from the United States account for up to 50% during certain periods. This patient group also includes individuals working in highly visible professions, including television, music and the performing arts. Their treatment requires a particularly discreet, flexible approach focused on long-term continuity of care.

Objective: This presentation introduces a treatment model developed in Mallorca to improve treatment engagement, clinical stability and long-term recovery among international patients with complex substance-use and mental-health disorders.

Treatment Model: Approximately €8 million has been invested in the clinic’s medical infrastructure and multidisciplinary treatment environment. The programme combines established medical, psychiatric and psychotherapeutic measures. These include comprehensive diagnostics, medically supervised withdrawal management where clinically required, pharmacological treatment, psychotherapy and structured relapse prevention.

These measures are complemented by carefully selected ketamine-assisted treatments where clinically indicated and legally permissible in the individual case.

The programme also includes an integrative medical pathway delivered in cooperation with an institute affiliated with the clinic. The integrative measures are intended to support—but never replace—evidence-based medical and psychotherapeutic treatment. Depending on the patient’s individual clinical indication, supportive measures may address sleep, stress regulation, physical recovery, nutrition and general health stabilisation.

A central element of the treatment model is the structured transition from residential or intensive treatment to comprehensive continuing care. Patients receive an individualised follow-up plan, continuous access to a 24-hour emergency telephone service and coordinated ongoing support. This enables a rapid response to psychological destabilisation, intense cravings or an increased risk of relapse. For international patients, continuing care may also involve coordination across countries and time zones.

Discussion and Conclusion: Our clinical experience to date suggests that combining conventional medical, psychiatric and psychotherapeutic care with complementary integrative medical measures and intensive post-treatment support may improve treatment engagement and continuity of care.

The presentation explains the structure and practical implementation of this treatment model, the specific requirements regarding discretion and confidentiality, and the practical experience gained to date. It also addresses the need for systematic outcome measurement and further scientific evaluation before general conclusions can be drawn regarding the effectiveness of the treatment model.